Data were collected from clinicians, including work experience, protocols or drug regimes used, personnel involved in PS, monitoring, time to recovery/discharge, side effects and complications experienced, and doctors' satisfaction with present PS practice.
Only participants who remained in follow-up on the study through to at least 48 weeks and who did not experience protocol-defined virologic failure at or before week 48 were included in this analysis of SCR.
We selected subjects enrolled in a phase IIb clinical trial of VVC who experienced protocol-defined virologic failure (<1 log10 viral load decrease at or after week 16) and a change in coreceptor usage as determined by a validated phenotypic assay (Trofile, Monogram Biosciences, South San Francisco, CA); subjects with assay-detectable CXCR4-using virus at baseline were excluded [13].
We selected subjects enrolled in a phase IIb clinical trial of VVC who experienced protocol-defined virologic failure and a change in coreceptor usage as determined by a validated phenotypic assay (Trofile, Monogram Biosciences, South San Francisco, CA), excluding subjects with assay-detectable CXCR4-using virus at baseline [13].
Patients in both treatment groups experienced protocol-defined AEs of special interest.
This analysis includes the 625 women who remained on-study through 48 weeks without experiencing protocol-defined virologic failure.
Integrated performance improvement: The introduction of CIV and RCIV packets in the proposed WF-MAC forces to experience more protocol operation overhead compared to others.
We consider the software issues involved in combining the best of SpaceWire, such as modularity, high speed, low latency, fault tolerance, and ease of implementation, with the vast experience of protocol design that has been implemented on Ethernet.
We consider the opportunities for combining the best of SpaceWire, such as modularity, high speed, low latency, fault tolerance, and ease of implementation, with the vast experience of protocol design that has been implemented on Ethernet.
In our experience, the protocol developed in this study is highly reliable and allows detection of BrdU and FISH signal on different targets, such as cells in interphase, metaphase chromosomes, and chromatin fibres.
